STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 62 filers reported holding STEMLINE THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $10,658,000 | -53.6% | 2,202,069 | +1.9% | 0.00% | -50.0% |
| Q4 2019 | $22,969,000 | +9.8% | 2,160,745 | +7.5% | 0.00% | 0.0% |
| Q3 2019 | $20,920,000 | -19.8% | 2,009,596 | +18.0% | 0.00% | 0.0% |
| Q2 2019 | $26,099,000 | +23.7% | 1,703,585 | +3.8% | 0.00% | 0.0% |
| Q1 2019 | $21,098,000 | +115.0% | 1,641,900 | +59.0% | 0.00% | +100.0% |
| Q4 2018 | $9,811,000 | -34.3% | 1,032,719 | +14.8% | 0.00% | 0.0% |
| Q3 2018 | $14,934,000 | -10.9% | 899,583 | -13.9% | 0.00% | 0.0% |
| Q2 2018 | $16,768,000 | +22.4% | 1,044,477 | +16.6% | 0.00% | 0.0% |
| Q1 2018 | $13,700,000 | +138.2% | 895,432 | +142.9% | 0.00% | – |
| Q4 2017 | $5,751,000 | +48.2% | 368,672 | +5.5% | 0.00% | – |
| Q3 2017 | $3,880,000 | +22.1% | 349,585 | +1.2% | 0.00% | – |
| Q2 2017 | $3,179,000 | +19.8% | 345,363 | +11.3% | 0.00% | – |
| Q1 2017 | $2,653,000 | -1.5% | 310,247 | +23.2% | 0.00% | – |
| Q4 2016 | $2,694,000 | +8.1% | 251,804 | +9.2% | 0.00% | – |
| Q3 2016 | $2,493,000 | +67.0% | 230,508 | +4.4% | 0.00% | – |
| Q2 2016 | $1,493,000 | +48.1% | 220,768 | +1.9% | 0.00% | – |
| Q1 2016 | $1,008,000 | -23.9% | 216,571 | +3.3% | 0.00% | – |
| Q4 2015 | $1,325,000 | -21.7% | 209,687 | +9.3% | 0.00% | – |
| Q3 2015 | $1,693,000 | -24.0% | 191,774 | +1.3% | 0.00% | – |
| Q2 2015 | $2,228,000 | -15.0% | 189,380 | +4.5% | 0.00% | – |
| Q1 2015 | $2,622,000 | -15.1% | 181,230 | -0.0% | 0.00% | – |
| Q4 2014 | $3,089,000 | +37.0% | 181,259 | +0.1% | 0.00% | – |
| Q3 2014 | $2,254,000 | +4.8% | 181,079 | +23.5% | 0.00% | – |
| Q2 2014 | $2,150,000 | -24.6% | 146,603 | +4.6% | 0.00% | – |
| Q1 2014 | $2,851,000 | -1.6% | 140,124 | -5.0% | 0.00% | – |
| Q4 2013 | $2,896,000 | -58.7% | 147,541 | -4.7% | 0.00% | -100.0% |
| Q3 2013 | $7,011,000 | +183.7% | 154,759 | +49.2% | 0.00% | – |
| Q2 2013 | $2,471,000 | – | 103,752 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 453,000 | $4,168,000 | 1.58% |
| Eventide Asset Management | 1,086,400 | $9,995,000 | 0.62% |
| SPHERA FUNDS MANAGEMENT LTD. | 300,000 | $2,760,000 | 0.47% |
| Lyon Street Capital, LLC | 125,595 | $1,155,000 | 0.46% |
| CARL DOMINO INC | 26,000 | $239,000 | 0.28% |
| PURA VIDA INVESTMENTS, LLC | 60,000 | $552,000 | 0.22% |
| KNOTT DAVID M | 41,692 | $384,000 | 0.16% |
| SABBY MANAGEMENT, LLC | 187,500 | $1,725,000 | 0.11% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,157,500 | $10,649,000 | 0.11% |
| Telemetry Investments, L.L.C. | 25,000 | $230,000 | 0.11% |